FDA investigating serious risk of T-cell malignancies in CAR-T cell therapy patients

 The FDA on Tuesday said it was looking into reports of T-cell malignancies in patients who have been treated with CAR-T cell immunotherapies.

https://seekingalpha.com/news/4040765-fda-investigating-serious-risk-of-t-cell-malignancies-in-car-t-cell-therapy-patients